It is reported that aberrantly excreted urinary O-glycosylated proteins (clusterin, leucine-rich alpha-2-glycoprotein, and kininogen) could serve as potential biomarkers for the early detection of early stage ovarian cancer [30]. The gene discussed is CLU; the disease is ovarian carcinoma.